Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: Primary structure, IGF-binding properties, and disulfide bonding pattern

Biochemistry

Volumn 44, Issue 9, 2005, Pages 3644-3652

  Mark, Silke ^a   Kübler, Bernd ^b   Höning, Stefan ^c   Oesterreicher, Sandra ^b   John, Harald ^a   Braulke, Thomas ^b   Forssmann, Wolf Georg ^a   Ständker, Ludger ^a  

^a IPF PHARMACEUTICALS GMBH   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHEMICAL BONDS; CHROMATOGRAPHIC ANALYSIS; HORMONES; SOLUTIONS;

BINDING ASSAYS; BINDING CAPACITY; CLEAVAGE SITES; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS (IGFBP);

PROTEINS;

ALANINE; ARGININE; GLUTAMIC ACID; GLUTAMINE; GLYCINE; INTEGRIN; LEUCINE; METHIONINE; PEPTIDE FRAGMENT; PEPTIDE LIBRARY; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 2; TYROSINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CHROMATOGRAPHY; CONTROLLED STUDY; DISULFIDE BOND; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN STRUCTURE;

ADULT; AMINO ACID SEQUENCE; CHYMOTRYPSIN; DISULFIDES; HEMOFILTRATION; HUMANS; HYDROLYSIS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS;

EID: 14644429001     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi0478401     Document Type: Article

References (50)

1. Rechler, M. M., and Brown, A. L. (1992) Insulin-like growth factor binding proteins: Gene structure and expression, Growth Regul. 2, 55-68.
2. Zapf, J. (1995) Physiological role of the insulin-like growth factor binding proteins, Eur. J. Endocrinol. 132, 645-654.
3. Jones, J. I., and Clemmons, D. R. (1995) Insulin-like growth factors and their binding proteins: Biological actions, Endocr. Rev. 16, 33-34.
4. Lalou, C., Lassarre, C., and Binoux, M. (1996) A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin, Endocrinology 137, 3206-3212.
5. Oh, Y., and Rosenfeld, R. G. (1999) IGF-independent actions of the IGF binding proteins, in The IGF System (Rosenfeld, R. G., and Roberts, C. T., Jr., Eds.) pp 257-272, Humana Press Inc., Totowa, NJ.
6. Firth, S. M., and Baxter, R. C. (2002) Cellular actions of the insulin-like growth factor binding proteins, Endocr. Rev. 23, 824-854.
7. Bunn, R. C., and Fowlkes, J. L. (2003) Insulin-like growth factor binding protein proteolysis, Trends Endocrinol. Metab. 14, 176-181.
8. Singh, B. K., Charkowicz, D. A., and Mascarenhas, D. D. (2004) IGF-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3, J. Biol. Chem. 279, 477-487.
9. Baxter, R. C. (2000) Insulin-like growth factor (IGF)-binding proteins: Interactions with IGFs and intrinsic bioactivities, Am. J. Physiol. Endocrinology Metab. 278, E967-E976.
10. Roghani, M., Lassarre, C., Zapf, J., Povoa, G., and Binoux, M. (1991) Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins, J. Clin. Endocrinol. Metab. 73, 658-666.
11. Wang, J. F., Hampton, B., Mehlman, T., Burgess, W. H., and Rechler, M. M. (1988) Isolation of a biologically active fragment from the carboxy terminus of the fetal rat binding protein for insulin-like growth factors, Biochem. Biophys. Res. Commun. 157, 718-726.
12. Forbes, B. E., Turner, D., Hodge, S. J., McNeil, K. A., Forsberg, G., and Wallace, J. C. (1998) Localization of an insulin-like growth factor (IGF) binding site of bovine IGF binding protein-2 using disulfide mapping and deletion mutation analysis of the C-terminal domain, J. Biol. Chem. 273, 4647-4652.
13. Ho, P. J., and Baxter, R. C. (1997) Characterization of truncated insulin-like growth factor-binding protein-2 in human milk, Endocrinology 138, 3811-3818.
14. Carrick, F. E., Forbes, B. E., and Wallace, J. C. (2001) BIAcore analysis of bovine insulin-like growth factor (IGF)-binding protein-2 identifies major IGF binding site determinants in both the amino- and carboxyl-terminal domains, J. Biol. Chem. 276, 27120-27128.
15. Ständker, L., Kübler, B., Obendorf, M., Braulke, T., Forssmann, W. G., and Mark, S. (2003) In vivo processed fragments of IGF binding protein-2 copurified with bioactive IGF-II, Biochem. Biophys. Res. Commun. 304, 708-713.
16. Conover, C. A., and Khosla, S. (2003) Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts, Growth Horm. IGF Res. 13, 328-335.
17. Russo, V. C., Bach, L. A., Fosang, A. J., Baker, N. L., Werther, G. A. (1997) Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb, Endocrinology 138, 4858-4867.
18. Fowlkes, J. L., Serra, D. M., Bunn, R. C., Thrailkill, K. M., Enghild, J. J., and Nagase, H. (2004) Regulation of insulin-like growth factor (IGF)-I action by matrix metalloproteinase-3 involves selective disruption of IGF-I/IGF-binding protein-3 complexes, Endocrinology 145, 620-626.
19. Shalamanova, L., Kübler, B., Scharf, J. G., and Braulke, T. (2001) MDCK cells secrete neutral proteases cleaving insulin-like growth factor-binding protein-2 to -6, Am. J. Physiol. Endocrinol. Metab. 281, E1221-E1229.
20. Maile, L. A., and Holly, J. M. (1999) Insulin-like growth factor binding protein (IGFBP) proteolysis: Occurrence, identification, role, and regulation, Growth Horm. IGF Res. 9, 85-95.
21. Shi, Z., Xu W., Loechel, F., Wewer, U. M., and Murphy, L. J. (2000) ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3, J. Biol. Chem. 275, 18574-18580.
22. Claussen, M., Kübler, B., Wendland, M., Neifer, K., Schmidt, B., Zapf, J., and Braulke, T. (1997) Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D, Endocrinology 138, 3797-3803.
23. Moralez, A., Busby, W. H., Jr., and Clemmons, D. (2003) Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells, Endocrinology 144, 2489-2495.
24. Booth, B. A., Boes, M., and Bar, R. S. (1996) IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding, and structure of fragments, Am. J. Physiol. 271, E465-E470.
25. Schulz-Knappe, P., Schrader, M., Ständker, L., Richter, R., Hess, R., Jürgens, M., and Forssmann, W. G. (1997) Peptide bank generated by large-scale preparation of circulating human peptides, J. Chromatogr., A 776, 125-132.
26. Mark, S., Forssmann, W. G., and Ständker, L. (1999) Strategy for identifying circulating fragments of insulin-like growth factor binding proteins in a hemofiltrate peptide bank, J. Chromatogr., A 852, 197-205.
27. Hossenlopp, P., Seurin, D., Segovia-Quinson, B., Hardouin, S., and Binoux, M. (1986) Analysis of serum insulin-like growth factor binding proteins using western blotting: Use of the method for titration of the binding proteins and competitive binding studies, Anal. Biochem. 154, 138-143.
28. Ständker, L., Braulke, T., Mark, S., Mostafavi, H., Meyer, M., Höning, S., Gimenez-Gallego, G., and Forssmann, W. G. (2000) Partial IGF affinity of circulating N- and C-terminal fragments of human insulin-like growth factor binding protein-4 (IGFBP-4) and the disulfide bonding pattern of the C-terminal IGFBP-4 domain, Biochemistry 39, 5082-5088.
29. Kübler, B., Draeger, C., John, H., Andag, U., Scharf, J. G., Forssmann, W. G., Braulke, T., and Ständker, L. (2002) Isolation and characterization of circulating fragments of the insulin-like growth factor binding protein-3, FEBS Lett. 518, 124-128.
30. Giudice, L. C., Farrell, E. M., Pham, H., and Rosenfeld, R. G. (1990) Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) and IGFBP-2 in human follicular fluid, J. Clin. Endocrinol. Metab. 71, 1330-1338.
31. Monget, P., Mazerbourg, S., Delpuech, T., Maurel, M. C., Maniere, S., Zapf, J., Lalmanach, G., Oxvig, C., and Overgaard, M. T. (2003) Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: Identification of cleavage site and characterization of IGFBP-2 degradation, Biol. Reprod. 68, 77-86.
32. Cohick, W. S., Gockerman, A., and Clemmons, D. R. (1993) Vascular smooth muscle cells synthesize two forms of insulin-like growth factor binding proteins which are regulated differently by the insulin-like growth factors, J. Cell. Physiol. 157, 52-60.
33. Elmlinger, M. W., Rauschnabel U., Koscielniak, E., Weber, K., Ranke, M. B. (1999) Secretion of noncomplexed 'Big' (10-18 kD) forms of insulin-like growth factor-II by 12 soft tissue sarcoma cell lines, Horm. Res. 52, 178-185.
34. Geisert, R. D., Chamberlain, C. S., Vonnahme, K. A., Malayer, J. R., and Spicer, L. J. (2001) Possible role of kallikrein in proteolysis of insulin-like growth factor binding proteins during the oestrous cycle and early pregnancy in pigs, Reproduction 121, 719-728.
35. Hossenlopp, P., Segovia, B., Lassarre, C., Roghani, M., Bredon, M, and Binoux, M. (1990) Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy, J. Clin. Endocrinol. Metab. 71, 797-805.
36. Bereket, A., Lang, C. H., Blethen, S. L., Fan, J., Frost, R. A., and Wilson, T. A. (1995) Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity, J. Clin. Endocrinol. Metab. 80, 2282-2288.
37. Whellams, E. J., Maile, L. A., Fernihough, J. K., Billingham, M. E., and Holly, J. M. (2000) Alterations in insulin-like growth factor binding protein-3 proteolysis and complex formation in the arthritic joint. J. Endocrinol. 165, 545-556.
38. Tönshoff, B., Blum, W. F., Wingen, A. M., and Mehls, O. (1995) Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J. Clin. Endocrinol. Metab. 80, 2684-2691.
39. Byun, D., Mohan, S., Yoo, M., Sexton, C., Baylink, D. J., and Qin, X. (2001) Pregnancy-associated plasma protein-A accounts for the insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) proteolytic activity in human pregnancy serum and enhances the mitogenic activity of IGF by degrading IGFBP-4 in vitro, J. Clin. Endocrinol. Metab. 86, 847-854.
40. Tönshoff, B., Schaefer, F., and Mehls, O. (1990) Disturbance of growth hormone-insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment, Pediatr. Nephrol. 4, 654-662.
41. Lee, K. O., Oh, Y., Giudice, L. C., Cohen, P., Peehl, D. M., and Rosenfeld, R. G. (1994) Identification of insulin-like growth factor-binding protein-3 (IGFBP-3) fragments and IGFBP-5 proteolytic activity in human seminal plasma: A comparison of normal and vasectomized patients, J. Clin. Endocrinol. Metab. 79, 1367-1372.
42. Powell, D. R., Durham, S. K., Liu, F., Baker, B. K., Lee, P. D., Watkins, S. L., Campbell, P. G., Brewer, E. D., Hintz, R. L., and Hogg, R. J. (1998) The insulin-like growth factor axis and growth in children with chronic renal failure: A report of the Southwest Pediatric Nephrology Study Group, J. Clin. Endocrinol. Metab. 83, 1654-1661.
43. McCusker, R. H., Cohick, W. S., Busby, W. H., and Clemmons, D. R. (1991) Evaluation of the developmental and nutritional changes in porcine insulin-like growth factor-binding protein-1 and -2 serum levels by immunoassay, Endocrinology 129, 2631-2638.
44. Roghani, M., Hossenlopp, P., Lepage, P., Balland, A., and Binoux, M. (1989) Isolation from human cerebrospinal fluid of a new insulin-like growth factor-binding protein with a selective affinity for IGF-II, FEBS Lett. 255, 253-258.
45. Elmlinger, M. W., Grund, R., Buck, M., Wollmann, H. A., Feist, N., Weber, M. M., Speer, C. P., and Ranke, M. B. (1999) Limited proteolysis of the IGF binding protein-2 (IGFBP-2) by a specific serine protease activity in early breast milk, Pediatr. Res. 46, 76-81.
46. Hobba, G. D., Forbes, B. E., Parkinson, E. J., Francis, G. L., and Wallace, J. C. (1996) The insulin-like growth factor (IGF) binding site of bovine insulin-like growth factor binding protein-2 (bIG-FBP-2) probed by iodination, J. Biol. Chem. 271, 30529-30536.
47. Horney, M. J., Evangelista, C. A., and Rosenzweig, S. A. (2001) Synthesis and characterization of insulin-like growth factor (IGF)-1 photoprobes selective for the IGF-binding proteins (IGFBPS). photoaffinity labeling of the IGF-binding domain on IGFBP-2, J. Biol. Chem. 276, 2880-2889.
48. Szabo, L., Mottershead, D. G., Ballard, F. J., and Wallace, J. C. (1988) The bovine insulin-like growth factor (IGF) binding protein purified from conditioned medium requires the N-terminal tripeptide in IGF-1 for binding, Biochem. Biophys. Res. Commun. 151, 207-214.
49. Chelius, D., Baldwin, M. A., Lu, X,. and Spencer, E. M. (2001) Expression, purification, and characterization of the structure and disulfide linkages of insulin-like growth factor binding protein-4, J. Endocrinol. 168, 283-296.
50. Schütt, B. S., Langkamp, M., Rauschnabel, U., Ranke, M. B., and Elmlinger, M. W. (2004) Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells, J. Mol. Endocrinol. 32, 859-868.